AstraZeneca’s bruising summer raises the stakes for 2027
When one of AstraZeneca’s medicines, Wainua, failed a major late-stage heart disease trial in July, it was a jarring setback for a drugmaker whose research pipeline had become one of the most admired in the ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.